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Background: The level of lactate in amniotic fluid may provide useful clinical information when assessing progress
of a woman’s labour and if so, a rapid, reliable method to assess amniotic fluid lactate is required in order to be
clinically relevant. However, measuring lactate levels in amniotic fluid, using portable, handheld lactate meters may
be less accurate than reference laboratory instruments designed to measure lactate levels in aqueous solutions.
Prior to conducting a large study, we assessed recruitment, consent and sampling procedures, and the accuracy
of a handheld lactate meter to measure lactate in amniotic fluid. We compared amniotic fluid lactate results
obtained using the hand held Lactate Pro (Arkray) to results obtained using reference laboratory methods ABX
Pentra 400 (Horiba).
Results: We recruited 35 nulliparous women during their antenatal hospital visits and tested amniotic fluid samples
collected from 20 labouring women. The handheld Lactate Pro meter was found accurate from 9–20 mmol/L with a
Passing & Bablok regression of y = 0.18 + 0.97x (95% CI 0.76–1.45). Amniotic fluid lactate results remained reliable in
the presence of potential contaminants commonly encountered during labour; obstetric lubricant, blood and
meconium.
Conclusion: The measurement of amniotic fluid lactate using the Lactate Pro meter was reliable compared to
reference laboratory methods for measuring lactate levels in amniotic fluid. The pilot study enabled the
refinement of information, recruitment, consenting and sampling procedures prior to commencing a large cohort
study.
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Lack of progress in labour (dystocia) is one of the
most commonly occurring problems requiring inter-
vention during labour [1]. In many industrialized coun-
tries labours are treated for dystocia by augmenting
with oxytocin to accelerate or improve progress [2,3].
However there is currently no accurate method for
predicting at the onset of augmentation who will pro-
gress to a vaginal birth or who will require a cesarean* Correspondence: Beverley.Hall@sesiahs.health.nsw.health.au
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reproduction in any medium, provided the orsection. In clinical practice, many labours deemed lack-
ing in progress result in a normal vaginal birth. Con-
versely, women augmented for slow progress in labour
may experience long painful labours that ultimately re-
sult in caesarean section.
Currently dystocia is diagnosed clinically by observing
factors such as slowing of cervical dilation, slowing of
descent and rotation of the fetal head, and changes in
strength, duration and frequency of uterine contractions
[4]. In the absence of a clear and consistent definition or
marker to guide decision making there is considerable
variation in diagnosis and clinical practice[5]. There is a
need for improved diagnostic methods and decision. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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duce the high rates of labour intervention attributable to
this condition.
Measurement of lactate in amniotic fluid of labouring
women may be a surrogate biochemical marker for
labour dystocia [6-9] based on the reasonable hypothesis
that dystocia is partly due to lactic acidosis of myometrial
tissue [10]. Recent physiological studies on the effects of
acidification of the uterus show human myometrium to
be sensitive to changes in pH, and that accumulation of
lactic acid in myometrium during contractions may re-
duce the strength of contractions [7,11]. More recent
studies of the acid–base balance of uterine tissue indicate
that MCT 4 proteins, which appear to be activated when
the myometrium is hypoxic, may be the mechanism by
which lactic acid in myometrium is transported to the
surrounding amniotic fluid [12].
If amniotic fluid lactate is relevant in the clinical
management of dystocia, it is essential that a rapid and
accurate test for amniotic fluid lactate is available. Al-
though measurement of lactate using laboratory based
spectrophotometric and fluorometric assays is possible
this is not clinically useful in diagnosing dystocia due to
time constraints in the clinical setting of active labour.
The Lactate Pro is a small, portable hand held device
used to process blood samples at the point of care
which is relatively inexpensive. It has the potential to
be used in rural and remote settings where laboratory
technology may be unavailable due to costs and /or op-
erator skill and has been found to be easy to operate
and accurate [13,14]. Manufacturer’s specifications indi-
cate the Lactate Pro meter measures lactate concentra-
tions in whole blood between 0.8 and 23 mmol/L and
previous tests of reliability in amniotic fluid show min-
imal measurement error with a coefficient of variation
of (1.7–3.0%) [15]. However, validation studies for use
of the Lactate Pro to test lactate in amniotic fluid are
not well described, and previous studies of amniotic
fluid lactate not sufficiently powered to determine the
utility of amniotic fluid lactate measurement for women
in labour.
This report describes an assessment of a handheld
meter (the Lactate Pro) for measuring amniotic fluid
lactate, prior to conducting a large prospective study.
The primary objectives of the pilot amniotic fluid lac-
tate study were to assess the consenting processes for
recruiting women to amniotic fluid lactate research and
evaluate methods of amniotic fluid collection. We also
aimed to determine the clinical aspects of relevant
confounding factors in the measurement of lactate in
amniotic fluid by contaminants, and determine the con-
cordance between bedside measurement of lactate using
the Lactate pro hand held meter and reference labora-
tory biochemical measurements.Methods
Pilot study population and eligibility criteria
Women who booked to give birth at a tertiary teach-
ing hospital between October 2011 and January 2012
were considered for inclusion. Nulliparous women with
a live, singleton cephalic fetus and a spontaneous onset
or induction of labour at 37–42 weeks gestation were
eligible to participate. A final decision regarding inclu-
sion was made when the woman was in labour to en-
sure the fetus remained in a cephalic presentation and
was not compromised, as evidenced by routine admis-
sion cardiotocography. Women were excluded if they
had a known fetal anomaly or a recognised contraindi-
cation to vaginal birth at the onset of labour. Three
women with a singleton fetus with polyhydramnios
undergoing elective amniocentesis in the third trimes-
ter of pregnancy were also recruited, in order to col-
lect amniotic fluid under sterile conditions. The Study
Protocol was approved by New South Wales Northern
Network Human Research Ethics Committee 11/140
through the National Ethics Application Form Submis-
sion AU/19E1A08.
Recruitment, consent and enrolment
Recruitment took place at antenatal visits at or after
36 weeks gestation at the Outpatient Department of a
public tertiary level teaching hospital. When a woman
who had consented to participate in the study arrived
at hospital in labour, or for an induction, the research
midwife was notified by staff. The research midwife
confirmed that all inclusion criteria and none of the
exclusion criteria were present and the woman was en-
rolled into the study, after giving verbal confirmation
of her consent to participate.
Sample collection and amniotic fluid testing in the
birthing room
Amniotic fluid samples were collected from labouring
women at the following defined time points after arrival
at the hospital. On admission if membranes were already
ruptured; at spontaneous rupture of membranes during
labour; at the time of artificial rupture of membranes; at
routine vaginal assessment of labour progress (usually
four hourly); prior to augmentation of labour; and at the
time of birth. Amniotic fluid was not collected if a
woman had not ruptured her membranes.
Non-invasive methods for collecting amniotic fluid
were trialled by the research midwife. It became appar-
ent that amniotic fluid was most easily collected at the
time of vaginal examination as the fluid pooled in the
cupped, gloved, palm of the examining clinician. Results
were obtained either by touching the primed Lactate Pro
test strip directly to the pooling fluid during the examin-
ation or, by collecting some of the pooling fluid in a
Table 1 Triplicate saline samples spiked for predicted Lo,











Saline Lo* 1.5 ± 0.2 7.0 ± 0.1 21.1 ± 0.2 Hi
Saline + fluoride
preservative Lo* 1.6 ± 0.6 6.8 ± 0.1 19.8 ± 0.2 Hi*
*Manufacturers instructions for the Lactate Pro indicate The Lactate Pro will
display “Lo” when lactate levels are below 0.8 mmol/L and “Hi” will be
displayed when lactate > 23.3 mmol.
Table 2 A comparison between Lactate Pro meter results
and the automated lactate analyser (Abx Pentra 400) of
amniotic fluid collected under sterile conditions and
spiked with a known quantity of lactate




Baseline 9.5 ± 0.1 10.0 ± 0.2
0.5 mM* 10.0 ± 0.1 10.6 ± 0.5
1.0 mM 10.5 ± 0.5 10.5 ± 0.1
5 mM 14.6 ± 0.6 14.2 ± 0.3
10 mM 21 ± 0.8 18.4 ± 0.1
20 mM Hi 26.3 ± 0.7
* Lactate concentration added (in addition to baseline levels of lactate in
amniotic fluid).
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copious flowing amniotic fluid, lactate was measured by
applying the primed test strip directly to a freshly ap-
plied perineal pad. In collections where a syringe was
used, if sufficient fluid was available, after testing with
the Lactate Pro, a portion of the sample was sent to the
laboratory for reference testing. In contrast, studies by
Wiberg Itzel et al. (2008) obtained amniotic fluid by
inserting a silicon catheter into the labouring uterus, via
the vagina. We did not adopt or test this method of
obtaining amniotic fluid as we aim to determine if amni-
otic fluid lactate, obtained at the time of routine examin-
ation by non-invasive methods, is a potential biomarker
for clinicians to assess progress of labour.
Amniotic fluid specimens were tested at the time of
collection using the Lactate Pro analyser according to
manufacturer’s instructions. Briefly, a test strip was
inserted into the Lactate Pro, ensuring correct orienta-
tion. The device, with test strip in situ was dipped in a
vertical position into the amniotic fluid sample. Results,
available within 1 minute were recorded by the research
midwife. In most cases, clinical staff remained blinded to
the result, except for teaching purposes where the re-
search midwife shared the results with clinical staff. Am-
niotic fluid lactate results were never considered in
clinical decision making.
Validation of point of care amniotic fluid lactate
measurement
Amniotic fluid lactate results were compared to vali-
dated reference laboratory techniques for measuring lac-
tate in aqueous fluids, the ABX Pentra 400 (Horiba
Medical) using the following methods.
At the time of point of care testing with the Lactate Pro,
where sufficient amniotic fluid sample was available, amni-
otic fluid was collected via syringe and inserted into so-
dium fluoride preservative tubes (Becton Dickinson).
Within one hour of collection amniotic fluid samples were
centrifuged at 8000×g for 2 minutes. The supernatant was
removed and stored at −20°C until analysis by the ABX
Pentra 400, courtesy of the Clinical Chemistry Laboratory
at South Eastern Area Laboratory Services, Randwick.
In order to determine if the sodium fluoride preserva-
tive used in sample preparation for the AbX Pentra 400
affected lactate levels, a minimum of 0.6 mL of saline
was added to the sodium fluoride tubes, then spiked
with lactate substrate (62 mmol/L) from the LDH12 kit
(Roche, SUI) to yield estimated low, high and midrange
values. The selected values were based on previous lac-
tate studies [8,15,16]. Saline samples without fluoride
preservative containing the same concentration of lac-
tate were also prepared. Each sample was prepared in
triplicate and measured using the Lactate Pro device
(Table 1).Samples of amniotic fluid collected under sterile con-
ditions were spiked with lactate and levels measured
using both the Lactate Pro and AbX Pentra 400. Baseline
biological lactate concentration was determined by test-
ing the amniotic fluid samples with the Lactate Pro
meter. A minimum of 0.6 mL of amniotic fluid was then
spiked with lactate to yield a predetermined lactate con-
centration (0.5 mM, 1.0 mM, 5 mM, 10 mM, 20 mM)
above baseline. Each concentration was prepared and
tested in triplicate. At the time of spiking, samples were
tested using the Lactate Pro meter, and the sample
centrifuged and stored until laboratory analysis by the
AbX Pentra, as described above (Table 2).
To assess the effect of potential amniotic fluid contami-
nants (meconium, obstetric cream surgical lubricant and
blood) which may confound amniotic fluid lactate results,
samples of amniotic fluid were prepared containing 1%,
5%, 10% and 20% [weight per volume (w/v) or volume per
volume v/v)] of the potential contaminants. The samples
were tested for baseline lactate concentration and prepared
in triplicate. Glove lubricant was not tested at 20% (v/v) as
the mixture was too viscous for analysis by the Lactate Pro
(Table 3).
As unintended delays may occur between the collection
and testing of samples in the clinical environment, we
performed a time series to determine the effect of time de-
lays (on lactate concentration). When sufficient quantity of
sample was available, after ascertaining baseline amniotic
Table 3 Assessment of variations in lactate concentration














Baseline 6.3 ± 0.9
1% (v/v) 5.9 ± 0.3
5% (v/v) 6.1 ± 0.3
10% (v/v) 6.4 ± 0.4
20% (v/v) 7.9 ± 0.5
Obstetric cream
Baseline 6.3 ± 0.9
1% (v/v) 6.4 ± 0.5
5% (v/v) 6.0 ± 0.5
10% (v/v) 5.9 ± 0.3
20% (v/v) 5.0 ± 0.1
Meconium
Baseline 7.8 ± 0.0
1% (w/v) 7.7 ± 0.3
5% (w/v) 7.4 ± 0.2
10% (w/v) 7.5 ± 0.3
20% (w/v) 7.7 ± 0.3
# Amniotic fluid was thawed from–20°C prior to use, except for glove lubricant
where amniotic fluid was fresh.






























Figure 1 Scatter plot with passing and Bablock Fit comparing
Lactate Pro and AbX amniotic fluid lactate results.
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remaining in the collecting syringe was re-tested after 5, 15
and 30 minutes to identify possible degradation of lactate.
Lactate stability studies were extended to 24 hours after
collection of two amniotic fluid samples collected under
sterile conditions (one spiked with 10 mmol/L lactate and
one sample unspiked); the spiked, non-centrifuged amni-
otic fluid samples were stored overnight at 4°C, then tested
after 1, 5, 15 and 30 minutes at room temperature.
Results
Validation of lactate Pro as an accurate measure of
amniotic fluid lactate
The lactate concentrations in saline samples with and
without fluoride preservative were almost identical
(Table 1). While average lactate concentrations measured
were similar, there was more variation in the samples
with preservative. This may have been due to a problem
of homogenization of the sample with the sodium fluor-
ide crystals, most likely a preanalytical problem than an
analytical variation of the device at low concentrations.
There was close concordance between results of lactate
levels on the two analysis systems (Lactate Pro, AbX Pentra400). Minor variation was apparent; mostly at high lactate
concentration (≥ 10 mmol/L), which are at the upper end
of the Lactate Pro analysis range as the Lactate Pro has a
narrower analysis range than the AbX Pentra (Table 2). A
Passing & Bablok regression line fitted to the results found
the Lactate Pro to be accurate from 9–20 mmol/L, with
y = 0.18 + 0.97x (95% CI 0.76–1.45) (Figure 1).
Assessment of potential confounders of lactate levels in
amniotic fluid
Amniotic fluid lactate increased in the presence of whole
blood (which has its own lactate load) and decreased in
the presence of other contaminants as the ratio of con-
taminant to amniotic fluid increased (Table 3). In the
time series analysis, samples collected during labour and
under surgical conditions indicated that lactate concen-
trations remained stable with no significant reduction in
measured lactate up to 30 min after initial collection, and
remained stable in samples refrigerated overnight and
tested at least 24 hours after collection (data not shown).
In total, 35 women were recruited to the study and 90 at-
tempts were made to collect amniotic fluid from 20
labouring women who gave birth during the study
timeframe. Amniotic fluid was not able to be collected
from 15 women as nine arrived in hospital in advanced
labour, three had reduced liquor volume diagnosed by
ultrasound, two had not given birth at the time of data ana-
lysis and one woman gave birth with intact membranes. A
lactate result was measured in 65/90 attempts to collect
amniotic fluid. Mucous samples appeared to prevent the
capillary action of the Lactate Pro test strip and no results
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obtained at the time of artificial rupture of membranes
performed to induce labour on 10 occasions; despite the
procedure, sufficient amniotic fluid for sampling was not
detectable at that time. Several other factors impacted on
successful readings for example, one ‘Lo’ result was
obtained from a sample collected directly after a woman
exited the bath (presumably bathwater contamination).
Two ‘Lo’ results were attributable to operator error (failure
to prime the test strip by inserting it into the meter prior
to collecting the sample). Outlier ‘Lo’ results were removed
from the analysis.
Discussion
Results show the handheld Lactate Pro meter to be reli-
able measuring lactate in amniotic fluid samples col-
lected and tested in controlled conditions. A Passing &
Bablok regression line applied to the lactate measures
shows the Lactate Pro meter accurate from 9–20 mmol/
when measuring lactate in amniotic fluid collected under
sterile conditions, compared to results from the refer-
ence analyser. A Passing Bablok regression was chosen
due to the small sample size, as it allows measurement
error (imprecision) in both the X and Y variables, does
not assume measurement error is normally distributed,
and is robust against outliers. The result compares
favourably with correlation reported by Tanner et al.
[14] comparing the accuracy of the Lactate Pro against a
laboratory-based a Radiometer ABL 700 analyser.
Our results support previous findings by others who
have assessed the Lactate Pro in amniotic fluid lactate
research [8,9,15] although we clearly outline the poten-
tial effects of contaminants on lactate levels and describe
collection methods that reflect clinical practice, not pre-
viously described to our knowledge. Reassuringly, we
established that possible contaminating substances en-
countered during labour do not alter amniotic fluid lactate
results to any great extent and our small time series leads
us to conclude that delays encountered in the clinical situ-
ation, prior to testing, do not unduly affect results.
Although the Amniotic Fluid Lactate™ monitoring sys-
tem is now available on the market prior to conducting
clinical trials to demonstrate the efficacy of amniotic
fluid lactate in obstetric clinical decision making [17], we
remain interested in exploring the utility of handheld
meters to test amniotic fluid lactate for the reasons of
cost efficiency, potential use in remote settings and ver-
satility, as handheld lactate members have also been clin-
ically evaluated to test fetal scalp and umbilical cord
lactate [18,19].
Conclusions
This small pilot study establishes proof of principle that
the Lactate Pro meter, a commercially available productvalidated to measure lactate in whole blood, is a reliable
measure of lactate in amniotic fluid, in samples collected
from women during labour after spontaneous or artifi-
cial rupture of membranes. Moreover, we found women
interested and willing to participate in amniotic fluid lac-
tate research, although it will be necessary to reduce se-
lection and sampling bias in future amniotic fluid lactate
research studies, in order to achieve valid results about
the association of lactate results with labour dystocia.
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